Objectives: to analyze the quality of life of "patients" with Human Immunodeficiency Virus
and relate it to their socioeconomic profile, knowledge and attitudes toward
sexuality. Method: crosssectional and analytical study with 201 individuals who are 50 years old or
older. The Targeted Quality of Life and Aging Sexual Knowledge and Attitudes
Scales were applied during interviews. Multiple Linear Regression was used in data
analysis. Results: dimensions of quality of life more strongly compromised were disclosure worries
(39.0), sexual function (45.9), and financial worries (55.6). Scores concerning
knowledge and attitudes toward sexuality were 31.7 and 14.8, respectively. There
was significant correlation between attitudes and the domains of overall function,
health worries, medication worries, and HIV mastery. Conclusion: guidance concerning how the disease is transmitted, treated and how it
progresses, in addition to providing social and psychological support, could
minimize the negative effects of the disease on the quality of life of patients
living with the Human Immunodeficiency Virus.
Nevirapine-induced DRESS syndrome is uncommon but a potentially life-threatening condition, with significant morbidity and mortality rates due to multiple-organ involvement. The authors report a case of a 47-year-old HIV-infected female patient who presented with fever, right hypochondrium pain, jaundice, and skin rash. The Nevirapine-induced DRESS syndrome was suspected based on clinical presentation and RegiSCAR scoring system. This case highlights the need for a high index of clinical suspicion among HIV-infected patients with severe skin eruption and systemic symptoms.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.